Information about Belantamab
Generic Name : BelantamabUp-to-date prescription details regarding Belantamab are provided here.
Pronunciation : bel an' ta mab
Learn the correct pronunciation of the Belantamab, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings and its and its storage instructions.You will also find a list of the medication's International and Indian brand or trade names, as well as its pricing information. For verification of the information presented on this page or for additional clarifications, it's advisable to consult your doctor.
Trade Names/Brand Names of Belantamab
India :
Blenrep
Overview of Belantamab
Belantamab is an anticancer agent indicated for the treatment of adults with multiple myeloma who have received at least four previous therapies. Multiple myeloma is a cancer that arises from white blood cell called the plasma cell.Why is Belantamab Prescribed? (Indications)
Belantamab is an anticancer agent indicated for the treatment of adults with multiple myeloma-A type of skin cancer.When should Belantamab not be taken? (Contraindications)
Patients allergic to BelantamabPregnant and lactating women
What is the dosage of Belantamab?
Belantamab is available as an injection.The recommended dosage is 2.5 mg/kg body weight, to be given as an intravenous infusion over half an hour once every 3 weeks.
How should Belantamab be taken?
Belnatamab is available for intravenous injectionWhat are the warnings and precautions for Belantamab?
•In case of any reactions, the dosage should be reduced to 1.9 mg/kg intravenously once every 3 weeks.• Patients should undergo regular eye assessments while using this medication.
• Patients should monitor serum creatinine, glucose, complete blood counts regularly while using this medication. Safety of usage was not established in children.
What are the side effects of Belantamab?
General: Fatigue, FeverDigestive: Nausea, vomiting, constipation, diarrhea, decreased appetite
Blood: Decreased platelet count, hemoglobin
Metabolic: Gamma glutamyl transferase levels may increase
Kidney: Creatinine levels may increase
Eye: corneal changes, decreased vision, blurred vision
Respiratory tract: Upper respiratory tract infection
What are the other precautions for Belantamab?
Patients with low platelet count should be careful. Regular platelet counts should be monitored.Infusion-related reactions can occur. If a reaction occurs, the infusion must be discontinued.
In women who are able to get pregnant, proper contraceptives should be used during the treatment and one week after the last dose is given.